Select Page

Author: Paul Riat

Brain-computer device cleared by FDA

The U.S. Food and Drug Administration authorized NeuroLutions to market its brain-computer interface device in April of this year. The Santa Cruz, CA company was founded in 2007, has research and funding ties to St. Louis. CrunchBase says it has brought in a combined $1.3M in VC from Ascension Ventures, Prolog Ventures, BioGenerator and an earlier seed round by St. Louis Arch Angels.

Read More